We now show that this rapid uptake is significantly attenuated by CLI‐095, the specific inhibitor of TLR4 in two breast carcinoma cell lines (Fig. 1A) both of which express TLR4 (Fig. 1B). The gene discussed is TLR4; the disease is breast carcinoma.